Amar D. Sharma

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Author Correction: Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Journal: Cell discovery

Published: December 10, 2025

Treatment of liver failure utilizing multi-cell lineage liver microtissue.

Treatment of liver failure utilizing multi-cell lineage liver microtissue.

Journal: JHEP reports : innovation in hepatology

Published: November 25, 2025

Impaired glycoRNA biogenesis in metabolic-dysfunction associated steatotic liver disease.

Impaired glycoRNA biogenesis in metabolic-dysfunction associated steatotic liver disease.

Journal: Journal of hepatology

Published: September 18, 2025

In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis.

In vivo base editing alleviates hepatic iron accumulation and fibrosis in models of HFE-related hereditary hemochromatosis.

Journal: Journal of hepatology

Published: July 15, 2025

Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease.

Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease.

Journal: Science advances

Published: April 09, 2025

Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Treatment of liver cirrhosis using hepatocyte-derived liver progenitor-like cells: a prospective, open-label, single-arm, safety trial.

Journal: Cell discovery

Published: February 26, 2025

MicroRNA-107 - a small RNA with a big impact on cytokinesis in hepatocellular carcinoma.

MicroRNA-107 - a small RNA with a big impact on cytokinesis in hepatocellular carcinoma.

Journal: Journal of hepatology

Published: September 25, 2024

MicroRNAs modulate SARS-CoV-2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2.

MicroRNAs modulate SARS-CoV-2 infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 07, 2024

Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosis.

Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosis.

Journal: Journal of hepatology

Published: January 14, 2024

Deconvolution of multichannel LC-MS/MS chromatograms of glucosamine-phosphates: Evidence of a GlmS regulatory difference between Staphylococcus aureus and Enterococcus faecium.

Deconvolution of multichannel LC-MS/MS chromatograms of glucosamine-phosphates: Evidence of a GlmS regulatory difference between Staphylococcus aureus and Enterococcus faecium.

Journal: Talanta open

Published: January 08, 2024

MicroRNA miR-20a-5p targets CYCS to inhibit apoptosis in hepatocellular carcinoma.

MicroRNA miR-20a-5p targets CYCS to inhibit apoptosis in hepatocellular carcinoma.

Journal: Cell death & disease

Published: December 07, 2023

Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses.

Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses.

Journal: Gut

Published: August 21, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026